Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Social Media Campaign for Latin Lupus Sufferers

Vanessa Caceres  |  Issue: January 2018  |  January 19, 2018

“Hablemos de Lupus does not address specific diagnosis or treatment recommendations,” Dr. Drenkard says. “Our responses provide general information about the topics raised and encourage participants to discuss their questions with their physicians.”

The information users obtain through Hablemos de Lupus is meant to complement what they get from their doctors. It doesn’t replace in-person meetings with fellow patients or doctor visits.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

A multidisciplinary team of lupus experts and rheumatologists, lupus education groups, patients and caregivers work with the initiative, in addition to a social media specialist, a creative producer and a webpage specialist. The rheumatologists are members of the Latin American Group for the Study of Lupus (GLADEL), an organization of nearly 90 rheumatologists from 36 centers across nine Latin American countries.

Hablemos also posts monthly live videos featuring a lupus expert. One recent live video discussed lupus and the kidneys. Led by an Argentinean rheumatologist, that video reached a peak of roughly 500 live views. “After 48 hours, there were 21,000 video views, over 4,000 reactions, 560 comments and nearly 700 shares,” Dr. Drenkard says.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

More Numbers

User numbers reveal the need for Hablemos de Lupus. After launching in early May 2017, Hablemos has amassed more than 50,000 Facebook followers, Dr. Drenkard says. People follow from every Latin American country, but most live in Mexico, Peru and Argentina. The page has also drawn followers from the U.S., Europe and Asia.

The initiative’s first YouTube video, “What Is Lupus?” (see below), recorded 3.3 million views in its first week and reached more than 14 million people within a month. “It’s a very clear sign this is something people want more information about,” Ms. Eberhardt says.

The average Facebook reader rating for Hablemos is currently 4.8 stars out of 5, compiled from roughly 300 reviews.

“Hablemos de Lupus is a low-cost, innovative model of health education and patient empowerment proven to be effective in reaching … a huge audience in a short time, which would be unrealistic through in-person meetings,” Dr. Drenkard says.

The Users

A diverse group of users across Latin America—from patients to their family members—connect and share their stories via Hablemos de Lupus. One example: Glenda Chávez of San Salvador, El Salvador. Ms. Chávez was diagnosed with lupus 10 years ago and has organized a group of roughly 70 people with lupus in her country around a Facebook page called Lupus El Salvador. Hablemos de Lupus and Ms. Chávez’ group help provide support and information in a country with very few rheuma­tologists and few resources to make lupus more understandable, Ms. Chávez says.

Page: 1 2 3 4 | Single Page
Share: 

Filed under:ConditionsSystemic Lupus ErythematosusTechnology Tagged with:LupusSocial MediaTechnology

Related Articles

    Navigating the Social Media Highway

    January 17, 2011

    Rheumatologists spot speed bumps, opportunities

    Patient Education Materials for Non-English Speakers

    July 10, 2023

    Recently, the Vasculitis Foundation, in collaboration with a group of physicians and vasculitis investigators in the U.S. and Latin America (i.e., Mexico, Colombia, Peru, Chile and Argentina), launched an educational series of videos in Spanish called, Aprendiendo de Vasculitis. “The goal of these videos is to provide education to all Spanish-speaking patients,” explains Sebastian E….

    Social Media Connects, Informs Rheumatologists

    April 26, 2018

    When Paul Sufka, MD, a rheumatologist with HealthPartners Medical Group and Regions Hospital in St. Paul, Minn., wants to connect with his colleagues or keep abreast of the latest rheumatology journal articles, he turns to Twitter. Dr. Sufka is one of many rheumatologists who have found effective ways to incorporate social media into their medical…

    How A Social Media Policy Can Protect Your Practice

    February 3, 2012

    While social media can be a beneficial marketing tool, it is important for rheumatologists to address the proper ways to use this outreach both inside and outside the workplace through a specific media policy

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences